Metagenomic Sequencing Market Report 2026

The metagenomic sequencing market size has grown rapidly in recent years. It will grow from $2.5 billion in 2025 to $2.92 billion in 2026 at a compound annual growth rate (CAGR) of 17.1%. The growth in the historic period can be attributed to increasing use of ngs, early adoption of microbial community studies, rising demand for dna extraction kits, growth in environmental microbiology research, expansion of clinical diagnostics.

The metagenomic sequencing market size is expected to see rapid growth in the next few years. It will grow to $5.14 billion in 2030 at a compound annual growth rate (CAGR) of 15.1%. The growth in the forecast period can be attributed to advancements in sequencing technologies, growth in microbiome-based therapeutics, increasing investment in bioinformatics, rising demand for cloud-based genomic analysis, expansion of precision medicine applications. Major trends in the forecast period include precision genomics expansion through high-throughput sequencing, AI-driven metagenomic data analysis, automation of sample preparation and sequencing workflows, cloud-based bioinformatics platforms for big data handling, iot-enabled environmental microbiome monitoring.

The increasing burden of tuberculosis (TB) is anticipated to drive the growth of the metagenomic sequencing market in the coming years. Tuberculosis is a contagious infectious disease caused by Mycobacterium tuberculosis, primarily affecting the lungs and transmitted through airborne droplets when infected individuals cough or sneeze. The rise in TB cases is attributed to factors such as global migration, weakened immune systems, antimicrobial resistance, and gaps in public health surveillance. Metagenomic sequencing aids TB detection by enabling rapid, unbiased identification of pathogens, identifying drug-resistance genes, and enhancing outbreak tracking, which are essential for managing evolving infectious threats. For example, in March 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, the number of tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023, marking an increase of 1,295 cases. Consequently, the growing burden of tuberculosis is fueling the expansion of the metagenomic sequencing market.

Major companies operating in the metagenomic sequencing market are concentrating on enhancing sequencing services to boost accuracy, throughput, and cost efficiency. Sequencing services encompass advanced genomic technologies that allow the sequencing of longer DNA fragments, offering a more complete understanding of genetic structures compared to conventional short-read approaches. For example, in April 2024, Clinical Microbiomics A/S, a Denmark-based biotechnology firm, introduced advanced long-read sequencing services, including 16S, ITS, 18S rRNA, custom gene sequencing, and comprehensive genomics and metagenomics. These services deliver exceptional resolution and quality in microbial analysis, enabling in-depth insights into microbial communities and supporting the development of high-quality metagenome-assembled genomes, along with technologies and bioinformatics services for microbial community (metagenomic) analysis, environmental, industrial, and microbiome-related applications.

In March 2024, Clinical Microbiomics A/S, a Denmark-based healthcare and biotechnology contract research organization specializing in microbiome and multi-omics services, acquired DNASense ApS for an undisclosed sum. Through this acquisition, Clinical Microbiomics enhanced its technological capabilities by incorporating long-read DNA and RNA sequencing along with advanced bioinformatics to improve metagenomic and multi-omics analyses. DNASense ApS is a Denmark-based biotechnology company that focuses on long-read DNA and RNA sequencing technologies and provides bioinformatics services for microbial community (metagenomic) analysis, as well as environmental, industrial, and microbiome-related applications.

Major companies operating in the metagenomic sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Eurofins Scientific SE, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Beijing Genomics Institute Group, Azenta Inc., Promega Corporation, Novogene Co. Ltd., Oxford Nanopore Technologies plc, Zymo Research Corporation, Metagenomi Inc., Psamogen Inc., IntegraGen SA, Karius Inc., DNAStar Inc., Macrogen Inc., Takara Bio Inc., Arc Bio LLC, Microsynth AG, Computomics GmbH, COSMOSID Inc., Phase Genomics Inc., Era7 Bioinformatics GmbH.

North America was the largest region in the metagenomic sequencing market in 2025. Asia-Pacific is expected to be the fastest growing region in the market. The regions covered in the metagenomic sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the metagenomic sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs on sequencing instruments, reagents, and analytical equipment have raised import costs and slowed procurement for biotechnology companies and research laboratories. Asia-Pacific and Latin America, which rely heavily on imported NGS platforms and bioinformatics hardware, experience the greatest delays and budget pressures. Despite added cost burdens, tariffs have encouraged domestic manufacturing of sequencing consumables and stimulated innovation in lower-cost data analysis solutions, ultimately reducing reliance on foreign suppliers in the long term.

The metagenomic sequencing market research report is one of a series of new reports that provides metagenomic sequencing market statistics, including metagenomic sequencing industry global market size, regional shares, competitors with a metagenomic sequencing market share, detailed metagenomic sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the metagenomic sequencing industry. This metagenomic sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Metagenomic sequencing is a method used to examine the genetic material of an entire community of microorganisms present in a specific environment, without requiring the cultivation of individual species. This approach involves extracting DNA directly from environmental samples, such as soil, water, or the human gut. The extracted DNA is subsequently sequenced using high-throughput sequencing technologies.

The primary products and services in the metagenomic sequencing market include reagents and consumables, instruments, sequencing services, and analysis and data interpretation solutions. Reagents and consumables encompass the chemical substances, kits, and disposable items utilized during laboratory experiments and procedures. The key technologies include 16S rRNA sequencing, shotgun metagenomic sequencing, whole-genome sequencing and de novo assembly, and metatranscriptomics, which are employed across various applications such as clinical diagnostics, environmental remediation, gut microbiome characterization, drug discovery, biofuel production, agriculture, and other areas.

The metagenomic sequencing market includes revenues earned by entities by providing services such as sample preparation, sequencing, metagenomic profiling, and data analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The metagenomic sequencing market also includes sales of sequencing platforms, bioinformatics software, DNA extraction kits, and sequencing reagents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.